Effects of the anticancer drug cocktail 'UFT' on metastatic potentials of squamous cell carcinoma (O-1N) in a hamster model

Oral Oncology

Volumn 34, Issue 5, 1998, Pages 326-331

  Naito, Y ^a   Kimura, S ^a   Yoshizawa, M ^a   Ohtake, K ^a   Nakajima, T ^a   Saku, T ^a  

^a NONE

Author keywords

Autoradiography; Lymph node metastasis; Oral cancer; Squamous cell carcinoma; UFT

Indexed keywords

UFT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MODEL; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SCREENING; HAMSTER; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TISSUE HOMOGENATE;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CRICETINAE; DRUG COMBINATIONS; LYMPHATIC METASTASIS; MALE; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION; TEGAFUR; URACIL;

EID: 0032167412     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00025-6     Document Type: Article

References (30)

1. Wilkinson D. S., Tlsty T. D., Hanas R. J. The inhibition of ribosomal RNA synthesis and maturation in Novikoff hepatoma cells by 5-fluorouridine. Cancer Research. 35:1975;3014-3020.
2. Ikenaka K., Shirasaka T., Kitano S., Fujii S. Effect of uracil on metabolism of 5-fluorouracil in vitro. Gann. 70:1979;353-359.
3. Hillers S. A., Zhuk R. A., Lidaks M. Analogs of pyrimidine nucleosides. Dokl Akad Nauk SSSR. 176:1967;332-335.
4. Fujii S., Kitano S., Ikenaka K., Shirasaka T. Effect of uracil and its derivatives on antitumour activity of 5-fluorouracil and 1-(2- tetrahydrofuryl)-5-fluorouracil. Gann. 69:1978;763-772.
5. Fujii S., Kitano S., Ikenaka S., Shirasaka T. Studies on coadministration of uracil or cytosine on antitumour activity of FT-207 or 5-FU derivatives. Jpn J Cancer Chemother. 6:1979;377-384.
6. Tsuru S., Togami M., Taniguchi M., Nomoto K. Effects of UFT on experimental liver metastases and on the immunologic capacity of the hosts. Jpn J Cancer Chemother. 15:1988;1915-1920.
7. Unemi N., Takeda S., Tajima K., Kawaguchi Y., Yasuda A. Studies on combination therapy with 1-(tetrahydro-2-furanyl)-5-fluorouracil plus uracil. I. Chemotherapy. 29:1981;164-175.
8. Nakajima O., Ihara K., Isoda T., et al. Phase I and II studies on a mixture of 1-(2-tetrahydrofuryl)-5-Fluorouracil and uracil (UFT). Jpn J Cancer Chemother. 7:1980;1558-1568.
9. Shingaki S, Takada M, Suzuki K, Nomura T, Nakajima T. Impact of clinico pathologic parameters on survival of patients with tongue carcinoma. Asian J Oral Maxillofac Surg, 1997;9:107-116.
10. Koida T., Kimura M. 5-FU concentration in the tissues (tumour and lymph node) of breast cancer patients given preoperative administration of UFT and FT. Jpn J Cancer Chemother. 12:1985;1147-1151.
11. Maeda M., Izumi A., Hamazoe R., Osaki Y., Shimizu N., Koga S. Intratumourous 5-FU concentration after coadministration of FT-207 with uracil. Strides of Medicine. 116:1981;97-100.
12. Suemasu K., Nomoto C., Higashi Y. Concentration of 5-FU level in the tissue and blood of the patients with breast cancer by preoperative administration of UFT. Jpn J Cancer Chemother. 9:1982;667-671.
13. Tanimura T., Kaneshige E., Fujiwara K., et al. 5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration. Jpn J Cancer Chemother. 13:1986;349-355.
14. Kusama M., Takahashi Y., Fujibayashi T., Itoh H., Soda T. Level of futraful (FT-207) and 5-FU in tumour tissues of the patients with head and neck malignant tumours after oral administration. Jpn J Cancer Chemother. 8:1981;1731-1741.
15. Kusama M., Utsunomiya Y., Ono T., Nagura H., Enomoto S. Level of 5-FU in tumour tissues of the patients with head and neck malignant tumours after oral administration of UFT. Jpn J Cancer Chemother. 10:1983;1786-1802.
16. Somekawa Y., Asano K., Taira A., Imai R. Determination of 5-FU tissue concentrations after oral UFT administration in tumours of the head and neck. Jpn J Cancer Chemother. 23:1996;75-79.
17. Ohtake K., Shingaki S., Nakajima T. A model for the study of lymph node metastasis from oral carcinoma by serial transplantation of metastatic tumour in hamsters. Oral Surg Oral Med Oral Pathol. 69:1990;701-707.
18. Marunaka T., Umeno Y., Yoshida K., Nagamachi M., Minami Y., Fujii S. High-pressure liquid chromatographic determination of ftorafur [1-(tetrahydro-2-furanyl)-5-fluorouracil] and GLC-mass spectrometric determination of 5-fluorouracil and uracil in biological materials after oral administration of uracil plus ftorafur. J Pharm Sci. 69:1980;1296-1300.
19. Kawaguchi Y., Nagayama S., Masuda H., Yasuda A. Studies on the metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil co-administered orally to tumour-bearing rats. Gann. 71:1980;889-899.
20. 3H-labeled UFTs in rats. Pharmacometrics. 3:1981;389-403.
21. Taguchi T., Nakano Y., Jikuy K., et al. Effect of uracil on the antitumour activity of futraful. Jpn J Cancer Chemother. 5:1978;1161-1165.
22. Taguchi T., Nakano Y., Fujii S., Shirasaka T. Determination of 5-fluorouracil levels in tumours, blood, and other tissues. Jpn J Cancer Chemother. 5:1978;1167-1172.
23. Taguchi T., Nakano Y. Attainability of anticancer drugs into the tumour - UFT therapy. Jpn J Cancer Chemother. 6:1979;257-263.
24. Tsujimoto T., Sakai S., Murata M., Sakai R. Concentrations of 5-FU in the tissue and serum of the patients with head and neck malignant tumours by preoperative administration of UFT. Jpn J Cancer Chemother. 10:1983;78-83.
25. Shingaki S., Nomura T., Kobayashi T., et al. Induction chemotherapy with methotrexate and bleomycin in squamous cell carcinoma of the head and neck. Asian J Oral Maxillofac Surg. 6:1994;41-47.
26. Cognetti F., Pinnaro P., Carlini P., et al. Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer. Cancer. 62:1988;251-261.
27. Kim J. A., Moore V. L., Didolkar M. S., Ordonez J. V., Vanweasep J. V., Sutter C. M. Flow cytometric analysis of primary and concurrent metastatic squamous cell carcinoma of the head and neck. Am J Surg. 158:1989;288-291.
28. Mahmood J. U., Suzuki K., Nomura T., Shingaki S., Nakajima T. The implication of DNA content and S-phase fraction in oral carcinomas with and without metastasis. Int J Oral Maxillofac Surg. 24:1995;427-432.
29. Suzuki K., Ruey B. C., Nomura T., Nakajima T. Flow cytometric analysis of primary and metastatic squamous cell carcinomas of the oral and maxillofacial region. J Oral Maxillofac Surg. 52:1994;855-861.
30. Sato N., Kawabe R., Umino S., et al. Cervical lymph node metastasis from oral cancer: evaluation by color Doppler imaging. Jpn J Oral Maxillofac Surg. 24:1995;427-432.